Project Grant R21MD020158
Award Date
9/22/24
Completion Date
6/30/26
Dollars Obligated
$216K
Federal Grant Program
93.307
Assistance Type
Project Grant
Place of Performance
Winston-Salem, NC 27157, USA
Similar Awards
This federal Project Grant award, valued at $801,832, was provided by the National Institute on Minority Health and Health Disparities (NIMHD) under the Minority Health and Health Disparities Research program (CFDA 93.307). The award aims to reduce disparities and the burden of lung cancer among African American smokers by supporting a multi-level integrated intervention that combines lung cancer screening using low-dose computed tomography (LDCT) and smoking cessation efforts. The key goals...
This Project Grant award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) provides $478,977 to the Morehouse School of Medicine to conduct a retrospective cohort study on racial disparities in lung cancer treatment and survival. The key objectives are to: Determine racial disparities in the receipt of cancer treatments, time to first treatment, number of treatment cycles, and dosage for non-small cell lung cancer (NSCLC) patients. Assess the...
This Project Grant award, in the amount of $269,942, was provided by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) federal grant program. The award aims to develop and pilot test a community health worker (CHW) intervention to improve lung cancer screening (LCS) uptake and address disparities in LCS among Black and Hispanic communities served by community health centers. The key products and services to be delivered include: 1) Jointly...
The U.S. National Cancer Institute (NCI) awarded a $158,290 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to Kaiser Foundation Hospitals to conduct a study on "Estimating Overdiagnosis After Implementation of Lung Cancer Screening in Community-Based Healthcare Systems." This 2-year project, running from July 2024 to July 2026, aims to produce estimates of overdiagnosis among patients diagnosed with lung cancer who participated in lung cancer...
This federal Project Grant award of $334,233, awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, will support a comprehensive research study examining disparities in novel cancer therapies, the joint effects of cancer treatment and comorbidities, and multi-level contributors to cancer survival outcomes. The University of South Carolina, the prime awardee, will conduct innovative data linkages between the state cancer registry,...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will provide $368,288 to Cleveland Clinic Lerner College of Medicine of Case Western Reserve University to conduct research aimed at understanding molecular mechanisms contributing to disparate lung cancer outcomes experienced by patients of African ancestry. The research project will: 1) Determine how EGFR signaling differs based on patient genetic ancestry, 2) Quantify the interplay...
This $306,999 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) is focused on developing an integrated machine learning framework to accurately identify lung cancer subtypes. The key products and services to be delivered include: Establishing a gene signature-transfer machine learning model that leverages large-scale bulk and single-cell transcriptomics data, both within and beyond NIH Common Fund...
This $146,868 Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Medical Library Assistance (CFDA 93.879) program will support the development of a user-centered cancer disparities visualization tool. The Medical University of South Carolina (MUSC) will utilize its integrated database system covering over 90% of low-income individuals in South Carolina to analyze colorectal, cervical, and breast cancer disparities among underserved populations. The...
The National Institute on Minority Health and Health Disparities (NIMHD) awarded a $3,794,331 Project Grant under the Minority Health and Health Disparities Research program (CFDA 93.307) to the Sloan-Kettering Institute for Cancer Research. The award, effective August 8, 2024 through February 28, 2029, will fund a study comparing three technology-enabled medical interpretation modalities - remote simultaneous, remote consecutive audio, and remote consecutive video - to improve cancer care...
The National Cancer Institute (NCI) awarded a $432,304 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to The Trustees of Columbia University in the City of New York, Health Sciences Division. The grant, awarded on January 3, 2025, supports a 5-year research project focused on "Enhanced Cancer Risk Predictions in Underrepresented Populations through Robust Multi-Source Data Integration." The project aims to develop novel data integration methods to...